JP2023500875A5 - - Google Patents
Info
- Publication number
- JP2023500875A5 JP2023500875A5 JP2022525715A JP2022525715A JP2023500875A5 JP 2023500875 A5 JP2023500875 A5 JP 2023500875A5 JP 2022525715 A JP2022525715 A JP 2022525715A JP 2022525715 A JP2022525715 A JP 2022525715A JP 2023500875 A5 JP2023500875 A5 JP 2023500875A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- cancer
- drug conjugate
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962932373P | 2019-11-07 | 2019-11-07 | |
| US62/932,373 | 2019-11-07 | ||
| PCT/IB2020/000917 WO2021090062A1 (en) | 2019-11-07 | 2020-11-06 | Anti-mesothelin eribulin antibody-drug conjugates and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023500875A JP2023500875A (ja) | 2023-01-11 |
| JP2023500875A5 true JP2023500875A5 (https=) | 2023-11-08 |
| JP7657213B2 JP7657213B2 (ja) | 2025-04-04 |
Family
ID=73943294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525715A Active JP7657213B2 (ja) | 2019-11-07 | 2020-11-06 | 抗メソテリンエリブリン抗体－薬物コンジュゲート及び使用方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11572414B2 (https=) |
| EP (1) | EP4055053A1 (https=) |
| JP (1) | JP7657213B2 (https=) |
| KR (1) | KR20220095197A (https=) |
| CN (1) | CN114729042B (https=) |
| AU (1) | AU2020380603A1 (https=) |
| BR (1) | BR112022008756A2 (https=) |
| CA (1) | CA3159541A1 (https=) |
| CO (1) | CO2022007924A2 (https=) |
| IL (1) | IL291643A (https=) |
| JO (1) | JOP20220070A1 (https=) |
| MX (1) | MX2022005221A (https=) |
| MY (1) | MY209745A (https=) |
| PE (1) | PE20230467A1 (https=) |
| PH (1) | PH12022551036A1 (https=) |
| TW (1) | TWI877249B (https=) |
| WO (1) | WO2021090062A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3801523B1 (en) | 2018-06-01 | 2024-09-11 | Eisai R&D Management Co., Ltd. | Splicing modulators |
| CN119405832A (zh) | 2018-06-01 | 2025-02-11 | 卫材R&D管理有限公司 | 剪接调节抗体-药物缀合物及其使用方法 |
| SG11202102419VA (en) | 2018-12-13 | 2021-04-29 | Eisai R&D Man Co Ltd | Herboxidiene splicing modulator antibody-drug conjugates and methods of use |
| WO2021090062A1 (en) | 2019-11-07 | 2021-05-14 | Eisai R&D Management Co., Ltd. | Anti-mesothelin eribulin antibody-drug conjugates and methods of use |
| AU2021284401A1 (en) | 2020-06-05 | 2023-01-05 | Eisai R&D Management Co., Ltd. | Anti-BCMA antibody-drug conjugates and methods of use |
| CA3225975A1 (en) * | 2021-07-22 | 2023-01-26 | Shanghai Senhui Medicine Co., Ltd. | Drug conjugate of eribulin derivative |
| WO2023016488A1 (zh) * | 2021-08-13 | 2023-02-16 | 昆山新蕴达生物科技有限公司 | 一种基于微管抑制剂的抗体偶联药物 |
| JP2024533356A (ja) * | 2021-09-16 | 2024-09-12 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド | 抗ｈｅｒ３抗体薬物複合体及びその組成物並びに用途 |
| TW202321296A (zh) | 2021-10-06 | 2023-06-01 | 美商鏈接免疫療法公司 | 抗間皮素抗原結合分子及其用途 |
| TW202518024A (zh) | 2023-10-13 | 2025-05-01 | 日商衛材R&D企管股份有限公司 | 抗體－藥物軛合物代謝物 |
| US20260048137A1 (en) * | 2024-08-16 | 2026-02-19 | Ardeagen Corporation | Anti-mesothelin antibody conjugates and methods of use thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4880078A (en) | 1987-06-29 | 1989-11-14 | Honda Giken Kogyo Kabushiki Kaisha | Exhaust muffler |
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| CA2109528A1 (en) | 1991-05-01 | 1992-11-02 | Gregory A. Prince | A method for treating infectious respiratory diseases |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| ATE508733T1 (de) | 1996-03-04 | 2011-05-15 | Penn State Res Found | Materialien und verfahren zur steigerung der zellulären internalisierung |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| CA2277801C (en) | 1997-01-16 | 2002-10-15 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US6653341B1 (en) | 1998-06-17 | 2003-11-25 | Eisai Co., Ltd. | Methods and compositions for use in treating cancer |
| JP4454151B2 (ja) | 1998-06-17 | 2010-04-21 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 大環状類似体及びそれらの使用並びに調製方法 |
| WO1999066903A2 (en) | 1998-06-24 | 1999-12-29 | Advanced Inhalation Research, Inc. | Large porous particles emitted from an inhaler |
| CN104955845B (zh) * | 2012-09-27 | 2018-11-16 | 美国政府(由卫生和人类服务部的部长所代表) | 间皮素抗体和引起有效的抗肿瘤活性的方法 |
| US10294304B2 (en) * | 2015-04-13 | 2019-05-21 | Pfizer Inc. | Chimeric antigen receptors targeting B-cell maturation antigen |
| SMT202000633T1 (it) | 2015-06-19 | 2021-01-05 | Eisai R&D Man Co Ltd | Immunoglobuline coniugate a cys80 |
| UA124622C2 (uk) | 2015-12-18 | 2021-10-20 | ЕЙСАЙ Ар ЕНД Ді МЕНЕДЖМЕНТ КО., ЛТД. | Кон'юговані імуноглобуліни з c-кінцевим лізином |
| WO2017136769A1 (en) | 2016-02-04 | 2017-08-10 | Eisai R&D Management Co., Ltd. | Peptide drug conjugates |
| PE20231050A1 (es) * | 2016-03-02 | 2023-07-11 | Eisai Randd Man Co Ltd | Conjugados de anticuerpo y farmaco basados en eribulina y metodos para su uso |
| CN119405832A (zh) | 2018-06-01 | 2025-02-11 | 卫材R&D管理有限公司 | 剪接调节抗体-药物缀合物及其使用方法 |
| SG11202102419VA (en) | 2018-12-13 | 2021-04-29 | Eisai R&D Man Co Ltd | Herboxidiene splicing modulator antibody-drug conjugates and methods of use |
| WO2021090062A1 (en) | 2019-11-07 | 2021-05-14 | Eisai R&D Management Co., Ltd. | Anti-mesothelin eribulin antibody-drug conjugates and methods of use |
| JP7821733B2 (ja) | 2020-01-22 | 2026-02-27 | 上海森輝医薬有限公司 | エリブリン誘導体の薬物複合体、その調製方法及びその医薬的応用 |
| AU2021284401A1 (en) | 2020-06-05 | 2023-01-05 | Eisai R&D Management Co., Ltd. | Anti-BCMA antibody-drug conjugates and methods of use |
-
2020
- 2020-11-06 WO PCT/IB2020/000917 patent/WO2021090062A1/en not_active Ceased
- 2020-11-06 KR KR1020227016852A patent/KR20220095197A/ko active Pending
- 2020-11-06 CN CN202080076659.9A patent/CN114729042B/zh active Active
- 2020-11-06 MY MYPI2022002370A patent/MY209745A/en unknown
- 2020-11-06 PE PE2022000738A patent/PE20230467A1/es unknown
- 2020-11-06 US US17/091,819 patent/US11572414B2/en active Active
- 2020-11-06 CA CA3159541A patent/CA3159541A1/en active Pending
- 2020-11-06 AU AU2020380603A patent/AU2020380603A1/en active Pending
- 2020-11-06 EP EP20828836.5A patent/EP4055053A1/en active Pending
- 2020-11-06 TW TW109138938A patent/TWI877249B/zh active
- 2020-11-06 MX MX2022005221A patent/MX2022005221A/es unknown
- 2020-11-06 BR BR112022008756A patent/BR112022008756A2/pt active Search and Examination
- 2020-11-06 JP JP2022525715A patent/JP7657213B2/ja active Active
- 2020-11-06 PH PH1/2022/551036A patent/PH12022551036A1/en unknown
-
2022
- 2022-03-17 JO JOP/2022/0070A patent/JOP20220070A1/ar unknown
- 2022-03-23 IL IL291643A patent/IL291643A/en unknown
- 2022-06-03 CO CONC2022/0007924A patent/CO2022007924A2/es unknown
- 2022-12-23 US US18/146,246 patent/US12564641B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023500875A5 (https=) | ||
| JP2020019787A5 (https=) | ||
| RU2018134331A (ru) | Конъюгаты антитело-лекарственное средство на основе эрибулина и способы применения | |
| ES2988698T3 (es) | Conjugados de fracciones de unión a la camptotecina | |
| JP5925875B2 (ja) | 抗体−薬剤コンジュゲート | |
| RU2483080C2 (ru) | Антитела и иммуноконъюгаты и их применение | |
| JP2021532063A5 (https=) | ||
| JP2019535731A5 (https=) | ||
| JP2025183307A5 (https=) | ||
| RU2016117810A (ru) | Конъюгаты белок-полимер-лекарственное средство | |
| JP2012522513A5 (https=) | ||
| RU2018119296A (ru) | Конъюгаты антитела, содержащие агонисты толл-подобного рецептора | |
| JP2016512832A5 (https=) | ||
| JP2020526584A5 (https=) | ||
| JP2022512401A5 (https=) | ||
| JP2022512401A (ja) | ハーボキシジエンスプライシング調節薬抗体－薬物コンジュゲート及びその使用方法 | |
| CN111295201A (zh) | 抗egfr抗体药物结合物（adc）和其用途 | |
| WO2023124963A1 (zh) | 一种可逆反应减少的抗体-药物偶联物，其制备方法及应用 | |
| JPWO2021251459A5 (https=) | ||
| JP2020532543A (ja) | 抗ｅｇｆｒ抗体薬物コンジュゲート（ａｄｃ）及びその使用 | |
| WO2023098691A1 (zh) | 抗体药物偶联物及其用途 | |
| JP2024519585A5 (https=) | ||
| CN105142664A (zh) | 投予抗gcc抗体-药物结合物和dna破坏剂来治疗癌症 | |
| CN120019074A (zh) | 与l1cam结合的新型结合分子 | |
| US20260007762A1 (en) | Anti-ror2 antibody-drug conjugates |